EP1908701A2 - Emballage blister pour comprimés - Google Patents

Emballage blister pour comprimés Download PDF

Info

Publication number
EP1908701A2
EP1908701A2 EP07388071A EP07388071A EP1908701A2 EP 1908701 A2 EP1908701 A2 EP 1908701A2 EP 07388071 A EP07388071 A EP 07388071A EP 07388071 A EP07388071 A EP 07388071A EP 1908701 A2 EP1908701 A2 EP 1908701A2
Authority
EP
European Patent Office
Prior art keywords
tablets
tablet
packaging
shell part
blister packaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07388071A
Other languages
German (de)
English (en)
Other versions
EP1908701A3 (fr
Inventor
Niels Ole Vesterager
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1908701A2 publication Critical patent/EP1908701A2/fr
Publication of EP1908701A3 publication Critical patent/EP1908701A3/fr
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/04—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills
    • B65D83/0445—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments
    • B65D83/0463—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments formed in a band or a blisterweb, inserted in a dispensing device or container

Definitions

  • the invention relates to a blister packaging for tablets, comprising a tablet part with a number of spaces for accommodating a number of tablets; a foil part for covering the tablets in the tablet part and through which one or more tablets can be pressed out of the packaging; and a shell part that can be arranged and secured on top of the tablet part opposite the foil part.
  • Blister packagings for tablets are known wherein the tablets are accommodated in each their space so as to prevent them from being shaken about in the packaging and destroyed.
  • each tablet is kept in position in the individual spaces until one or more tables are pressed out through the foil or the film to enable use of the tablet.
  • pills for medical use are concerned, meaning that various kinds of pills are concerned, be it pills against headache, allergy, sore throat, etc. Vitamin pills may also be concerned.
  • Such blister packages are known from GB 1,099,499 that show a tablet part in which a number of tablets can be arranged and a foil attached to the underside of the tablet part. When they are to be used, the tablets may be pressed out through the foil one at a time. To further protect them against being crushed or destroyed, e.g. when kept in a pocket or the like, some kind of lid is hingedly connected to the tablet part, which may be snapped across the tablet part and yield additional protection against the tablets being accidentally crushed.
  • the protection lid being transparent, one is obviously able to see the tablets through the lid.
  • the lid being openable and closable, it is also an option to use the space between the tablet part and the lid to advantage for insertion of informative or sales material, since such material could be seen by the user through the transparent protective lid.
  • blister packagings may be used for other kinds of tablets, eg tables that are useable within the cleaning sector or within other fields where it is not the intention that the tablets are to be ingested, but rather that they are to be used in some other context.
  • the tablets Since very often the tablets look alike or, at least, do not differ substantially from each other, whether used against headache or are to be added to liquid or the like in order to eg impart a cleaning effect to the tablet, it is important to be able to distinguish such tablets from each other prior to their being used in order to thereby prevent confusion from readily occurring.
  • One way of relatively easily safeguarding against this is to make sure that a user does not readily take the packaging and, without reading the packaging and based on the appearance of the tablet, believes it to be eg a headache pill.
  • the informative labelling and warnings may be lost when the tablets are pressed out through the rear side of the blister.
  • the labelling On the rear side, which is often constituted by an aluminium foil with warning text applied, the labelling will be lost.
  • the text on the rear side of the blister is also found on the back of the box in which the blister is sold, but often the outer packaging is disposed off, following which only the blister packaging as such remains; and the text on the rear disappearing in pace with the tablets being pressed out through the foil, the informative labelling also disappears.
  • this is obtained by providing a shell part that conceals the tablets and by attaching the shell part on top of the tablet part.
  • the attachment may be accomplished by means of welding, gluing or the like suitable methods.
  • the blister packaging with a shell part with a layer on top of the tablet part on the side of the tablet part that faces away from the foil part, said layer being non-transparent, it is not possible to see the tablet and hence it is not possible to confuse the tablet with eg a headache pill.
  • the shell part is glued, welded or otherwise permanently attached to the tablet part, whereby it is not possible to inadvertently remove the shell part from the tablet part.
  • the shell part as such may be manufactured from non-transparent material, optionally provided with printed text.
  • the shell part is manufactured from a non-transparent material
  • the tablet part may be configured such that several tablets can be pressed out at a time. This is particularly advantageous in cases where eg the size of the tablets influence the dosage. Those may be cases where the opening through which the tablets are to be added or dosed is so small that the size of a tablet should have to contain the appropriate amounts of active matter makes such tablet too large to pass through the delivery opening.
  • a blister packaging 1 comprises a tablet part 2 with a number of compartments 3 in which tablets 4 can be arranged, a shell part 5 and, if the shell part 5 is transparent, an insert sheet 6 and a sealing foil 7 or the like, through which a tablet 4 can be pressed out when the tablet 4 is to be used. If more than one tablet 4 is needed, the requisite number of tablets 4 can be pressed out of each their compartment 3 until the requisite number has been obtained.
  • the compartments 3 in the tablet part 2 are configured to each accommodate one tablet 4, to the effect that the tablets 4 can be kept in place in the packaging 1 and are unable to rattle around and bump into the remaining tablets 4 in the packaging.
  • a sealing foil 7 or the like on the open side of the tablet part 2, which is the side from where the tablets 4 are introduced prior to sealing, it is accomplished that the tablets 4 are kept in place in their respective compartments and that the tablets do not absorb moisture, which may otherwise deteriorate the properties of the tablet 4 and optionally reduce its performance.
  • tablets 4 packed in such packages 1 are better protected during transport and storage than tablets 4 that are merely packed in large amounts in the same container.
  • the shell part 5 may be a trough-shaped part that accurately fits across the tablet part 2, where test may be applied onto the outwardly facing side of the shell part 5, or a label 6, a sheet or the like may be arranged in the shell part 5.
  • the shell part 5 is joined with the tablet part 2 that contains the tablets 4 to the effect that the label or the sheet 6 remains unharmed when the tablets are pressed out through the rear side 7 of the blister packaging which often consists of aluminium, cardboard carton or a thin blister foil; for instance the blister foil 7 may consist of PCC, PVdC or the like suitable materials.
  • the shell part 5 may be manufactured from a transparent material of the same type as the configured tablet part 2. In those cases a label or a sheet 6 featuring information or informative labelling is laid between the tablet part 2 and the shell part 5 to the effect that the text on the label or the sheet 6 can be read when shell part 5 and tablet part 2 are joined.
  • the tablets not being directly visible it is an option to provide, in the shell part 5, a number of indications 9 showing where to apply pressure on the shell part 5 to press out the tablet 4 through the rear side of the foil 7.
  • Label or sheet 6 is adapted to the shell part 5 to the effect that the major part of the shape of the tablets 4 is not visible.
  • the label or the sheet 6 may be configured with foldable sides 8, said sides extending from the label or the sheet 6 and down over/around the tablet part 2 and covering up the tablets 4 to make them non-visible.
  • the shell part 5 may be coloured such that the tablet part 2 that contains the tablets 4 is not visible.
  • the shell part 5 may also have coloured sides, to the effect that it is only the side or the bottom of the shell part 5 where the label or the sheet is inserted that is transparent.
  • a non-detachable label 11 may be adhered to the inwardly facing side of the shell part 5 and, likewise, a label may be printed onto the outwardly facing side.
  • an extra space 10 may be formed, preferably at the end of or along the side of the packaging 1.
  • the space may be formed as a punching or an embossment in the tablet part 2.
  • a label 11 may be inserted or adhered.
  • a non-transparent shell part 5 may then be applied by welding or gluing or the like on top of the tablet part 2.
  • the shell part 5 may also consist of deformable carton or cardboard. In those cases the same indications and text must be printed onto the outside of the shell part. In that case the shell part must be manufactured and processed such that it can be attached to the shell part 2 by welding, gluing or the like methods.
  • a simplified method is to glue a simple, non-detachable label directly onto the tablet part 2.
  • the foil 7 For attaching the foil 7 to the tablet part 2 it is an option to have a particular welding mould 12 in which punch-outs are made between holes opposite the compartments 3 in the tablet part 2 and between holes opposite the compartments 3 in the tablet part 2 for each tablet and towards the rim of the welding mould corresponding to the edge of the packaging.
  • the packagings may be manufactured with any number of rows both in the longitudinal direction of the packaging and transversely of the packaging.
  • the compartments 3 or the blisters may be configured such that it is possible to press more than one tablet 4 out by applying pressure onto one blister 3 or a group of blisters 15. This may be accomplished by adapting the depth of a compartment or blister 3 for being able to receive more than one tablet 4, such that the tablets 4 rest against each other on their flat sides and are secured between the bottom of the blister 3 and the foil 7 to the effect that the tablets 4 are unable to move substantially relative to each other.
  • a tablet portion 2 may be configured to dose more than one tablet 4 by being pressed out from the tablet part 2 is by having groups 15 of blisters 3 that are arranged in the tablet part 2 so that more than one tablet 4 is released by activation of a group 15 of blisters 3.
  • a number of elevations or depressions 16 may be provided in the tablet part 2.
  • Such elevations or depressions 16 in the tablet part 2 may be arranged such that there is open space for passage of air between the individual blisters 3 in a group 15, but no space for free passage to the surroundings.
  • embodiments may be concerned where ventilation ducts are formed for being able to convey excess pressure, if any, out of each group 15 of blisters 3, but not from the surroundings and into the packaging.
  • a part of the elevations or depressions 16 in the tablet part 2 extend only partially down into the tablet part, whereas other elevations or depressions 16 are secured to the foil 7.
  • the number of blisters 3 in a group 15 is determined by the number of tablets 4 necessary for efficient dosage.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Packages (AREA)
EP07388071A 2006-10-06 2007-10-05 Emballage blister pour comprimés Withdrawn EP1908701A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK200601302A DK200601302A (da) 2006-10-06 2006-10-06 Blisteremballage til tabletter

Publications (2)

Publication Number Publication Date
EP1908701A2 true EP1908701A2 (fr) 2008-04-09
EP1908701A3 EP1908701A3 (fr) 2008-08-27

Family

ID=38683438

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07388071A Withdrawn EP1908701A3 (fr) 2006-10-06 2007-10-05 Emballage blister pour comprimés

Country Status (2)

Country Link
EP (1) EP1908701A3 (fr)
DK (1) DK200601302A (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2376348A1 (fr) * 2008-12-10 2011-10-19 Merck Sharp & Dohme Corp. Emballage pour produits pharmaceutiques sensibles à l oxygène
US9150119B2 (en) 2013-03-15 2015-10-06 Aesynt Incorporated Apparatuses, systems, and methods for anticipating and delivering medications from a central pharmacy to a patient using a track based transport system
US9511945B2 (en) 2012-10-12 2016-12-06 Aesynt Incorporated Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1099499A (en) * 1964-11-26 1968-01-17 Aspro Nicholas Ltd Improvements relating to the packaging of tablets
US3933245A (en) * 1973-07-09 1976-01-20 Mullen Patrick E Article holding and dispensing container
US4169531A (en) * 1977-08-18 1979-10-02 Packaging Components Industries, Inc. Plastic container with individual product pockets
AU7268981A (en) * 1980-07-11 1982-09-16 Airlite Packaging Pty. Ltd. Laminated cellular container for making ice shapes
FR2593152B1 (fr) * 1986-01-22 1988-12-23 Adir Conditionnement etanche sous forme de plaquettes alveolaire permettant des echanges gazeux entre les alveoles.
US4838425A (en) * 1987-12-17 1989-06-13 Warner-Lambert Company Tamper indicator for a blister package
JPH0471560A (ja) * 1990-07-10 1992-03-06 Mect Corp 包装体
CH688372A5 (de) * 1994-12-08 1997-08-29 Alusuisse Lonza Services Ag Blisterpackung.
GB9525065D0 (en) * 1995-12-07 1996-02-07 Smithkline Beecham Plc Packaging system
US20030234203A1 (en) * 2002-06-21 2003-12-25 Urban Joseph J. Blister package
EP1631509A4 (fr) * 2003-05-20 2008-04-09 Smithkline Beecham Corp Plaquettes alveolaires de securite pour enfants utilisant des structures a parois renfermant un medicament

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2376348A1 (fr) * 2008-12-10 2011-10-19 Merck Sharp & Dohme Corp. Emballage pour produits pharmaceutiques sensibles à l oxygène
EP2376348A4 (fr) * 2008-12-10 2012-09-05 Merck Sharp & Dohme Emballage pour produits pharmaceutiques sensibles à l oxygène
US9511945B2 (en) 2012-10-12 2016-12-06 Aesynt Incorporated Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility
US10029856B2 (en) 2012-10-12 2018-07-24 Aesynt Incorporated Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility
US10315851B2 (en) 2012-10-12 2019-06-11 Aesynt Incorporated Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility
US10518981B2 (en) 2012-10-12 2019-12-31 Aesynt Incorporated Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility
US10850926B2 (en) 2012-10-12 2020-12-01 Omnicell, Inc. Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility
US11694782B2 (en) 2012-10-12 2023-07-04 Omnicell, Inc. Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility
US9150119B2 (en) 2013-03-15 2015-10-06 Aesynt Incorporated Apparatuses, systems, and methods for anticipating and delivering medications from a central pharmacy to a patient using a track based transport system

Also Published As

Publication number Publication date
DK200601302A (da) 2008-04-07
EP1908701A3 (fr) 2008-08-27

Similar Documents

Publication Publication Date Title
US10266335B2 (en) Container with customisable opening-and-closing mechanism of inner package
RU2622803C2 (ru) Емкость с адгезивной этикеткой с областью, свободной от адгезива
US8567606B2 (en) Book-like packaging structure for receiving a blister pack
RU2555642C2 (ru) Обернутая емкость с адгезивной этикеткой
CA2377758C (fr) Emballage carton-coque destine a un produit sensible contenant des composants volatils et/ou sensibles a l'humidite
US20060231447A1 (en) Blister pack for smoking articles
NZ264840A (en) Hydrophilic contact lens pack; lens in sterile solution in moulded base member which is in a flexible cover sheet
CA2491007A1 (fr) Conditionnement pour distribution de portions individuelles
ES2565833T3 (es) Embalaje con dispositivo de control de presión, pieza postiza para el mismo y procedimiento para su fabricación
ES2668638T3 (es) Dispensadores de productos comestibles y métodos de fabricación y utilización de los mismos
EP1908701A2 (fr) Emballage blister pour comprimés
EP3393422B1 (fr) Contenant sous forme d`emballage-coque
JPH0924971A (ja) コンタクトレンズ用包装容器
EP1378459B1 (fr) Emballage à sandwich
CN210417623U (zh) 贴盖式包装容器
US20120199511A1 (en) Packaging for two different blisters
JP5564502B2 (ja) フィルム容器
US20040222280A1 (en) Lidded container
AU2007101229A4 (en) Cold Seal Foil
EP3194293A1 (fr) Support pour un médicament, en particulier dans une dose unitaire
US20050079249A1 (en) Sandwich packaging
KR20080087201A (ko) 보호시트가 추가된 블리스터 팩키지
JP2015072350A (ja) 医薬品バーコード複合シールおよび医薬品収容箱

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

17P Request for examination filed

Effective date: 20090226

17Q First examination report despatched

Effective date: 20090406

AKX Designation fees paid

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AXX Extension fees paid

Extension state: HR

Payment date: 20090226

Extension state: RS

Payment date: 20090226

Extension state: AL

Payment date: 20090226

Extension state: BA

Payment date: 20090226

Extension state: MK

Payment date: 20090226

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20171212

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180424